C-HV3HTAmiRNA
RNA biomarkers, microRNA diagnostics, extracellular vesicles
modulatingrna therapeutic
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-HV3H
C-HV3HC-HV3HRNA biomarkers, microRNA diagnostics, extracellular vesicles
0-100 chain-logic scale · 15 dimensions · scored on public evidence
TAmiRNA states that age-associated disorders can be better diagnosed and treated by harnessing microRNAs as diagnostic and therapeutic tools. The company presents personalized medicine for aging as its core approach, aiming to improve stability and quality of life with increasing age through early disease risk assessment and combined therapeutic solutions, drawing on research into intracellular and secreted (exosomal) microRNAs and their role in biological homeostasis.
SourceTAmiRNA states that aging and age-related diseases can be better addressed by identifying and characterizing microRNAs involved in these processes, then using that knowledge to develop personalized diagnostic tests and therapeutic drugs. The company says its goal is to improve patient stability and quality of life with increasing age through early disease risk assessment and combined therapeutic treatment solutions.
SourceTAmiRNA states that microRNAs are small non-coding RNA molecules that contribute to aging and the development of age-related diseases, and that identifying and characterizing these molecules can enable novel diagnostic tests and therapeutic drugs. The company says it uses this knowledge to support personalized treatment, early risk assessment, and combined therapeutic solutions aimed at improving patient stability and quality of life with increasing age.
Source